Quality of care assessment and improvement in aortic stenosis - rationale and design of a multicentre registry (IMPULSE)

Research output: Contribution to journalArticle

Standard

Quality of care assessment and improvement in aortic stenosis - rationale and design of a multicentre registry (IMPULSE). / Frey, Norbert; Steeds, Richard P; Serra, Antonio; Schulz, Eberhard; Baldus, Stephan; Lutz, Matthias; Pohlmann, Christiane; Kurucova, Jana; Bramlage, Peter; Messika-Zeitoun, David.

In: BMC Cardiovascular Disorders, Vol. 17, 5, 05.01.2017.

Research output: Contribution to journalArticle

Harvard

Frey, N, Steeds, RP, Serra, A, Schulz, E, Baldus, S, Lutz, M, Pohlmann, C, Kurucova, J, Bramlage, P & Messika-Zeitoun, D 2017, 'Quality of care assessment and improvement in aortic stenosis - rationale and design of a multicentre registry (IMPULSE)', BMC Cardiovascular Disorders, vol. 17, 5. https://doi.org/10.1186/s12872-016-0439-4

APA

Frey, N., Steeds, R. P., Serra, A., Schulz, E., Baldus, S., Lutz, M., Pohlmann, C., Kurucova, J., Bramlage, P., & Messika-Zeitoun, D. (2017). Quality of care assessment and improvement in aortic stenosis - rationale and design of a multicentre registry (IMPULSE). BMC Cardiovascular Disorders, 17, [5]. https://doi.org/10.1186/s12872-016-0439-4

Vancouver

Author

Frey, Norbert ; Steeds, Richard P ; Serra, Antonio ; Schulz, Eberhard ; Baldus, Stephan ; Lutz, Matthias ; Pohlmann, Christiane ; Kurucova, Jana ; Bramlage, Peter ; Messika-Zeitoun, David. / Quality of care assessment and improvement in aortic stenosis - rationale and design of a multicentre registry (IMPULSE). In: BMC Cardiovascular Disorders. 2017 ; Vol. 17.

Bibtex

@article{291480d3a2c743b0a83b7b07baacd6d9,
title = "Quality of care assessment and improvement in aortic stenosis - rationale and design of a multicentre registry (IMPULSE)",
abstract = "BACKGROUND: Severe aortic stenosis (AS) is a common, serious valve disease in which no effective medical therapy is available and, if not treated by intervention, has a 5-year survival of only 40-60%. Despite the availability of guidelines supporting the effective use of surgical aortic valve replacement (SAVR) or transcatheter aortic valve implantation (TAVI) to treat the majority of these patients, adherence to these guidelines in clinical practice is still unsatisfactory. Several recent studies have emphasised the necessity for improved communication between multidisciplinary teams, with the aim to ensure that severe AS patients receive appropriate treatment.METHODS/DESIGN: IMPULSE is a prospective, multicentre, European registry designed to gather data over 12 months on the treatment decisions made by referring physicians for patients newly diagnosed with severe AS. Each patient has a follow-up of 3 months. The study will consist of two observational phases to assess the appropriateness and rate of referral based on current guidelines prior to and after an interventional phase aiming to determine whether a simple quality of care intervention improves patient management.DISCUSSION: Data will be analysed firstly, to determine the appropriateness of treatment decisions for the management of severe AS in current European clinical practice, and secondly, to evaluate the effectiveness of facilitated data relay from a designated echocardiography department nurse to the referring physician early after diagnosis in improving quality of care. Additionally, variables will be identified that are associated with inappropriate decision-making. Collectively, the aim will be to design a clinical pathway that will improve the timely management of patients with newly diagnosed severe AS.",
keywords = "Journal Article",
author = "Norbert Frey and Steeds, {Richard P} and Antonio Serra and Eberhard Schulz and Stephan Baldus and Matthias Lutz and Christiane Pohlmann and Jana Kurucova and Peter Bramlage and David Messika-Zeitoun",
year = "2017",
month = jan,
day = "5",
doi = "10.1186/s12872-016-0439-4",
language = "English",
volume = "17",
journal = "BMC Cardiovascular Disorders",
issn = "1471-2261",
publisher = "Springer",

}

RIS

TY - JOUR

T1 - Quality of care assessment and improvement in aortic stenosis - rationale and design of a multicentre registry (IMPULSE)

AU - Frey, Norbert

AU - Steeds, Richard P

AU - Serra, Antonio

AU - Schulz, Eberhard

AU - Baldus, Stephan

AU - Lutz, Matthias

AU - Pohlmann, Christiane

AU - Kurucova, Jana

AU - Bramlage, Peter

AU - Messika-Zeitoun, David

PY - 2017/1/5

Y1 - 2017/1/5

N2 - BACKGROUND: Severe aortic stenosis (AS) is a common, serious valve disease in which no effective medical therapy is available and, if not treated by intervention, has a 5-year survival of only 40-60%. Despite the availability of guidelines supporting the effective use of surgical aortic valve replacement (SAVR) or transcatheter aortic valve implantation (TAVI) to treat the majority of these patients, adherence to these guidelines in clinical practice is still unsatisfactory. Several recent studies have emphasised the necessity for improved communication between multidisciplinary teams, with the aim to ensure that severe AS patients receive appropriate treatment.METHODS/DESIGN: IMPULSE is a prospective, multicentre, European registry designed to gather data over 12 months on the treatment decisions made by referring physicians for patients newly diagnosed with severe AS. Each patient has a follow-up of 3 months. The study will consist of two observational phases to assess the appropriateness and rate of referral based on current guidelines prior to and after an interventional phase aiming to determine whether a simple quality of care intervention improves patient management.DISCUSSION: Data will be analysed firstly, to determine the appropriateness of treatment decisions for the management of severe AS in current European clinical practice, and secondly, to evaluate the effectiveness of facilitated data relay from a designated echocardiography department nurse to the referring physician early after diagnosis in improving quality of care. Additionally, variables will be identified that are associated with inappropriate decision-making. Collectively, the aim will be to design a clinical pathway that will improve the timely management of patients with newly diagnosed severe AS.

AB - BACKGROUND: Severe aortic stenosis (AS) is a common, serious valve disease in which no effective medical therapy is available and, if not treated by intervention, has a 5-year survival of only 40-60%. Despite the availability of guidelines supporting the effective use of surgical aortic valve replacement (SAVR) or transcatheter aortic valve implantation (TAVI) to treat the majority of these patients, adherence to these guidelines in clinical practice is still unsatisfactory. Several recent studies have emphasised the necessity for improved communication between multidisciplinary teams, with the aim to ensure that severe AS patients receive appropriate treatment.METHODS/DESIGN: IMPULSE is a prospective, multicentre, European registry designed to gather data over 12 months on the treatment decisions made by referring physicians for patients newly diagnosed with severe AS. Each patient has a follow-up of 3 months. The study will consist of two observational phases to assess the appropriateness and rate of referral based on current guidelines prior to and after an interventional phase aiming to determine whether a simple quality of care intervention improves patient management.DISCUSSION: Data will be analysed firstly, to determine the appropriateness of treatment decisions for the management of severe AS in current European clinical practice, and secondly, to evaluate the effectiveness of facilitated data relay from a designated echocardiography department nurse to the referring physician early after diagnosis in improving quality of care. Additionally, variables will be identified that are associated with inappropriate decision-making. Collectively, the aim will be to design a clinical pathway that will improve the timely management of patients with newly diagnosed severe AS.

KW - Journal Article

U2 - 10.1186/s12872-016-0439-4

DO - 10.1186/s12872-016-0439-4

M3 - Article

C2 - 28056819

VL - 17

JO - BMC Cardiovascular Disorders

JF - BMC Cardiovascular Disorders

SN - 1471-2261

M1 - 5

ER -